X

About this post

Source
Author
Date
7:10 PM | February 20, 2013
Language
English
Categories
URL
Link to this page


Norwegian molecular diagnostics company Genetic Analysis is planning to bring its first CE-marked kit for diseases related to gut imbalances, GA-map IBS, to market in third quarter 2013. GA-map IBS is designed to differentiate people with irritable bowel syndrome (IBS) from patients with other gut disorders, including other forms of inflammatory bowel disease (IBD).

Tags

Comments

Log in to leave a comment